The Effect of Kinesio Taping® on Motor Control in Patients With Patellofemoral Pain Syndrome

NCT ID: NCT03117205

Last Updated: 2017-04-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-12-10

Study Completion Date

2017-01-23

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Background: Recently, several professionals are using the Kinesio Taping® in the treatment of pathologies related to the knee, aiming to improve the motor control, increase the response of muscle activation and promoting better joint stability.

Purpose: The objective of this study is to evaluate the effect of the application of Kinesio Taping® in motor control of patients with patellofemoral pain syndrome.

Methods: This is a 2-arm, randomized with a blinded assessor. We selected 40 women with patellofemoral pain (age 25.2±4,years) were randomly assigned to one of two groups: placebo group (n= 20) and the Kinesio Taping® group (n=20). The placebo group received the application of a non-stretchable tape (Micropore) crosswise on the thigh and the Kinesio Taping® group followed all the criteria of the method in placing the bandage. All patients received the evaluation of the motor control banding pre and post a patch, by means of the method Y balance test.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Knee Injuries Pain Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Kinesio Taping® group

Group Type EXPERIMENTAL

Application of Kinesio Taping®

Intervention Type OTHER

The technique was applied following the methods described in the original method for patellofemoral instability

placebo group

Group Type PLACEBO_COMPARATOR

Kinesio Taping® placebo application

Intervention Type OTHER

Simulation of the application of the Kinesio Taping® technique.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Application of Kinesio Taping®

The technique was applied following the methods described in the original method for patellofemoral instability

Intervention Type OTHER

Kinesio Taping® placebo application

Simulation of the application of the Kinesio Taping® technique.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patellofemoral pain syndrome diagnoses
* Aged 18-40 years
* Kujala questionnaire above

Exclusion Criteria

* Neurological disorders
* BMI indicating obesity (BMI\> 30kg / m²)
* High-performance athletes
* History of surgeries in lower limbs
* In treatment of any underlying pathology
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Faculdade de Ciências Médicas da Santa Casa de São Paulo

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Claudio Cazarini Junior

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

36422114.2.0000.5512

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.